Why is Astec Lifescienc falling/rising?

As of 25-Aug, Astec Lifesciences Ltd is experiencing a decline in its stock price, currently at Rs 857.05, which represents a decrease of Rs 55.95 or 6.13%. The stock has underperformed its sector by 6.29% today, touching an intraday low of Rs 857.05. Over the past week, the stock has shown a positive return of 6.49%, but it has declined by 4.00% over the past month and has a year-to-date drop of 14.72%. The company has reported negative results for the last five consecutive quarters, with significant operating losses and a low ability to service debt, indicated by a high Debt to EBITDA ratio of 2.64 times. This weak financial performance, coupled with a negative EBITDA and a substantial decline in profits over the past year, has contributed to the stock's recent downward movement.
In the broader market context, while the Sensex has shown a modest increase of 0.45% over the past week, Astec Lifesciences Ltd has consistently underperformed against this benchmark, with a staggering 55.11% decline over the past three years compared to a 38.90% increase in the Sensex. The stock's performance has been particularly poor, with a year-over-year return of -30.45%, highlighting its struggle to keep pace with the broader market trends. Despite a rise in investor participation, the overall negative sentiment surrounding the company's financial health and consistent underperformance against the benchmark suggests that the stock is facing significant challenges.